Studies of the use of gene therapy for revascularization in peripheral vascular disease patients were described at AHA by Dr. Drasko Simovic of St. Elizabeth’s Medical Center (Boston, Massachusetts). Simovic’s studies involved the intramuscular injection of a gene encoding for VEGF in patients suffering from peripheral neuropathy of the leg.
Of a total of 22 patients evaluated at three months, 63% had improved neurological symptoms, and 50% had an improvement in nerve motor amplitude. Furthermore, the ankle-brachial index improved in eight of 10 patients. The studies indicated that some reversal of diabetic neuropathy occurred due to gene treatment, whereas reversal of neuropathy in the legs has generally been considered to be irreversible…